BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3247823)

  • 1. The analysis of differentiation inhibitory factor to erythroid progenitor cells.
    Murate T; Kaneda T
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1581-9. PubMed ID: 3247823
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of erythropoiesis and hormone sensitivity by RNA tumor viruses.
    Hankins WD; Kaminchik J
    Prog Clin Biol Res; 1984; 148():141-52. PubMed ID: 6589645
    [No Abstract]   [Full Text] [Related]  

  • 3. B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.
    Feldman L; Frazier JG; Sytkowski AJ
    Exp Hematol; 1992 Nov; 20(10):1223-8. PubMed ID: 1426102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the human erythroid progenitor cells responsive to the erythropoietic-enhancing activity found in normal human serum.
    Mouchiroud G; Blanchet JP
    Int J Cell Cloning; 1987 Nov; 5(6):492-503. PubMed ID: 3429934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony formation in agar by adult bone marrow multipotential hemopoietic cells.
    Johnson GR
    J Cell Physiol; 1980 Jun; 103(3):371-83. PubMed ID: 7400223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythrocyte structure and differentiation].
    Partanen S; Jansson SE
    Duodecim; 1981; 97(7):385-93. PubMed ID: 7274112
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythroid-potentiating activity: characterization and target cells.
    Gauwerky CE; Lusis AJ; Golde DW
    Exp Hematol; 1980; 8 Suppl 8():117-27. PubMed ID: 6984393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine erythroid colony-promoting factor derived from thymocyte conditioned media.
    Maeda H; Hotta T; Yamada H
    Exp Hematol; 1983 Oct; 11(9):834-40. PubMed ID: 6605867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
    Roodman GD; Bird A; Hutzler D; Montgomery W
    Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differentiation of hematopoietic cells in long-term bone marrow culture.
    Salvado AJ; Meagher RC; Wright DG
    Kroc Found Ser; 1984; 18():273-92. PubMed ID: 6597868
    [No Abstract]   [Full Text] [Related]  

  • 11. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
    Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
    J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Culture of erythropoietic precursors.
    Hara H
    Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1346-51. PubMed ID: 751417
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors controlling the differentiation and cancerization of murine erythroleukemia cells].
    Obinata M
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):1989-95. PubMed ID: 3475040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
    Imamura M; Zhu X; Han M; Kobayashi M; Hashino S; Tanaka J; Kobayashi S; Kasai M; Asaka M
    Exp Hematol; 1996 Sep; 24(11):1280-8. PubMed ID: 8862438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
    Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
    Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythroid progenitor cells: their relevance for the study of haematological disease.
    Testa NG
    Clin Haematol; 1979 Jun; 8(2):311-33. PubMed ID: 385198
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropeptide modulation of murine erythropoiesis.
    Skelly RR; Fata J; Sharkis SJ; Sensenbrenner L; Ansari AA
    Ann Clin Lab Sci; 1987; 17(5):324-30. PubMed ID: 2823680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.